APP and Alzheimer disease: The effects of soluble Aβ include impaired synaptic transmission, typically observed in mouse models in which point mutations in the amyloid precursor protein (APP) or other AD-linked genes lead to APP overexpression and Aβ accumulation [12]–[21].